State holidays; Blood Plasma Donation Awareness Day; designate
Summary
HB 620 amends Georgia’s holidays and observances code to designate February 17 of each year as “Blood Plasma Donation Awareness Day” in the state. The bill is primarily commemorative and educational: it sets out legislative findings describing the importance of plasma donations, the medical uses of plasma-derived therapies, and the role of plasma collection centers in healthcare.
The findings also emphasize the connection between plasma donation and treatment of conditions such as sickle cell disease, hemophilia, autoimmune disorders, and rare immune deficiencies. The bill highlights the historical contributions of Dr. Charles Richard Drew and notes disparities in plasma collection ownership and representation, particularly in relation to communities of African descent.
Impact
The bill would add a new Code section to Title 1, Chapter 4 of the Official Code of Georgia Annotated, creating an annual state observance rather than regulating conduct or funding a program. Its legal effect is limited to formally recognizing February 17 as Blood Plasma Donation Awareness Day, with an effective date of July 1, 2026. It does not appear to impose new duties on state agencies, private entities, or donors, but it may be used to support public awareness efforts around plasma donation and related health issues.
Sentiment
The available text suggests generally positive, supportive sentiment toward the bill. The findings frame plasma donation as life-saving and socially important, and the bill appears intended to honor donors, raise awareness, and encourage broader participation in the plasma collection system. No committee transcript or vote record is available, so there is no direct evidence of opposition or debate in the provided materials.
Contention
Because there are no committee transcripts or recorded votes in the provided context, no specific points of contention are documented. The bill’s findings do, however, point to themes that could draw discussion, including racial representation in the plasma industry, the role of plasma collection centers, and the emphasis on sickle cell disease and communities of color. Any disagreement would likely center on the necessity or symbolism of creating a state observance rather than on regulatory or fiscal impacts.